Yaz

Yasmin/Yaz  Birth Control Drugs Linked to Blood Clots, Heart Attack and Other Life-Threatening Side Effects

 The oral contraceptive drugs Yasmin and Yaz have both been linked to serious, life-threatening injuries including blood clot, stroke, heart attack and death.  Yasmin and Yaz are known as combination oral birth control drugs because they contain a combination of the hormones estrogen (ethinyl estradiol) and progestin (drospirenone). Yasmin was approved for use in the United States in 2001, while Yaz, a lower dose version, was approved for use in 2006.  A generic version of Yasmin, marketed as Ocella, has been on the market since 2008. The difference between the two is in the amount of the estrogen component, ethinyl estradiol. Yasmin contains 30 mcg ethinyl estradiol, while Yaz contains a lower dose of 20 mcg. 

Side Effects Associated with Yasmin and Yaz

Both Yaz and Yasmin have been linked to serious, life-threatening side effects including:

• Blood Clots
• Strokes
• Heart Attacks
• Myocardial Infarction
• Pulmonary Embolism
• Kidney Failure
• Death
• Gallbladder Disease
• Liver Disease
• Liver Tumors

Please fill out the form below to contact a Case Manager.